A 65-year-old with chronic HFrEF (LVEF 30%) remains symptomatic despite maximally tolerated ARNI, β‑blocker, MRA, and SGLT2 inhibitor. He had a recent...

Question

A 65-year-old with chronic HFrEF (LVEF 30%) remains symptomatic despite maximally tolerated ARNI, β‑blocker, MRA, and SGLT2 inhibitor. He had a recent HF hospitalization 8 weeks ago. Which add‑on may reduce HF hospitalization risk?

Accepted Answer

Vericiguat

Answer

Ivabradine

Answer

Isosorbide mononitrate alone

Answer

Amlodipine

Answer

Amiodarone

us-abim MCQ (SBA): Heart Failure-Vericiguat

A 65-year-old with chronic HFrEF (LVEF 30%) remains symptomatic despite maximally tolerated ARNI, β‑blocker, MRA, and SGLT2 inhibitor. He had a recent HF hospitalization 8 weeks ago. Which add‑on may reduce HF hospitalization risk?